Literature DB >> 22257897

Postpartum and depression status are associated with lower [[¹¹C]raclopride BP(ND) in reproductive-age women.

Eydie L Moses-Kolko1, Julie C Price, Katherine L Wisner, Barbara H Hanusa, Carolyn C Meltzer, Sarah L Berga, Anthony A Grace, Teresa Lanza di Scalea, Walter H Kaye, Carl Becker, Wayne C Drevets.   

Abstract

The early postpartum period is associated with increased risk for affective and psychotic disorders. Because maternal dopaminergic reward system function is altered with perinatal status, dopaminergic system dysregulation may be an important mechanism of postpartum psychiatric disorders. Subjects included were non-postpartum healthy (n=13), postpartum healthy (n=13), non-postpartum unipolar depressed (n=10), non-postpartum bipolar depressed (n=7), postpartum unipolar (n=13), and postpartum bipolar depressed (n=7) women. Subjects underwent 60 min of [¹¹C]raclopride-positron emission tomography imaging to determine the nondisplaceable striatal D₂/₃ receptor binding potential (BP(ND)). Postpartum status and unipolar depression were associated with lower striatal D₂/₃ receptor BP(ND) in the whole striatum (p=0.05 and p=0.02, respectively) that reached a maximum of 7-8% in anteroventral striatum for postpartum status (p=0.02). Unipolar depression showed a nonsignificant trend toward being associated with 5% lower BP(ND) in dorsal striatum (p=0.06). D₂/₃ receptor BP(ND) did not differ significantly between unipolar depressed and healthy postpartum women or between bipolar and healthy subjects; however, D₂/₃ receptor BP(ND) was higher in dorsal striatal regions in bipolar relative to unipolar depressives (p=0.02). In conclusion, lower striatal D₂/₃ receptor BP(ND) in postpartum and unipolar depressed women, primarily in ventral striatum, and higher dorsal striatal D₂/₃ receptor BP(ND) in bipolar relative to unipolar depressives reveal a potential role for the dopamine (DA) system in the physiology of these states. Further studies delineating the mechanisms underlying these differences in D₂/₃ receptor BP(ND), including study of DA system responsivity to rewarding stimuli, and increasing power to assess unipolar vs bipolar-related differences, are needed to better understand the affective role of the DA system in postpartum and depressed women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257897      PMCID: PMC3327847          DOI: 10.1038/npp.2011.328

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  67 in total

1.  Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration.

Authors:  Drake Morgan; Kathleen A Grant; H Donald Gage; Robert H Mach; Jay R Kaplan; Osric Prioleau; Susan H Nader; Nancy Buchheimer; Richard L Ehrenkaufer; Michael A Nader
Journal:  Nat Neurosci       Date:  2002-02       Impact factor: 24.884

2.  Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus.

Authors:  Ornella Valenti; Daniel J Lodge; Anthony A Grace
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

3.  Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.

Authors:  R V Parsey; M A Oquendo; Y Zea-Ponce; J Rodenhiser; L S Kegeles; M Pratap; T B Cooper; R Van Heertum; J J Mann; M Laruelle
Journal:  Biol Psychiatry       Date:  2001-09-01       Impact factor: 13.382

Review 4.  Hypothalamic interaction with the mesolimbic DA system in the control of the maternal and sexual behaviors in rats.

Authors:  Danielle S Stolzenberg; Michael Numan
Journal:  Neurosci Biobehav Rev       Date:  2010-10-16       Impact factor: 8.989

5.  Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels.

Authors:  Wayne C Drevets; Joseph L Price; Mark E Bardgett; Theodore Reich; Richard D Todd; Marcus E Raichle
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

6.  Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat.

Authors:  Frances A Champagne; Pablo Chretien; Carl W Stevenson; Tie Yuan Zhang; Alain Gratton; Michael J Meaney
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

7.  Dopamine transmission in the human striatum during monetary reward tasks.

Authors:  David H Zald; Isabelle Boileau; Wael El-Dearedy; Roger Gunn; Francis McGlone; Gabriel S Dichter; Alain Dagher
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

8.  Dopamine D2 receptors in depression measured with single photon emission computed tomography.

Authors:  H A D'haenen; A Bossuyt
Journal:  Biol Psychiatry       Date:  1994-01-15       Impact factor: 13.382

Review 9.  Paternal postpartum depression, its relationship to maternal postpartum depression, and implications for family health.

Authors:  Janice H Goodman
Journal:  J Adv Nurs       Date:  2004-01       Impact factor: 3.187

10.  Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Authors:  Carlos A Zarate; Jennifer L Payne; Jaskaran Singh; Jorge A Quiroz; David A Luckenbaugh; Kirk D Denicoff; Dennis S Charney; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2004-07-01       Impact factor: 13.382

View more
  13 in total

1.  Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Authors:  Jennifer C Felger; Jiyoung Mun; Heather L Kimmel; Jonathon A Nye; Daniel F Drake; Carla R Hernandez; Amanda A Freeman; David B Rye; Mark M Goodman; Leonard L Howell; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

2.  Gestational stress induces persistent depressive-like behavior and structural modifications within the postpartum nucleus accumbens.

Authors:  Achikam Haim; Morgan Sherer; Benedetta Leuner
Journal:  Eur J Neurosci       Date:  2014-10-31       Impact factor: 3.386

Review 3.  Understanding Peripartum Depression Through Neuroimaging: a Review of Structural and Functional Connectivity and Molecular Imaging Research.

Authors:  Christy Duan; Jessica Cosgrove; Kristina M Deligiannidis
Journal:  Curr Psychiatry Rep       Date:  2017-08-19       Impact factor: 5.285

Review 4.  The maternal reward system in postpartum depression.

Authors:  Caitlin Post; Benedetta Leuner
Journal:  Arch Womens Ment Health       Date:  2018-12-15       Impact factor: 3.633

Review 5.  In search of neural endophenotypes of postpartum psychopathology and disrupted maternal caregiving.

Authors:  E L Moses-Kolko; M S Horner; M L Phillips; A E Hipwell; J E Swain
Journal:  J Neuroendocrinol       Date:  2014-10       Impact factor: 3.627

6.  The influence of motherhood on neural systems for reward processing in low income, minority, young women.

Authors:  Eydie L Moses-Kolko; Erika E Forbes; Stephanie Stepp; David Fraser; Kate E Keenan; Amanda E Guyer; Henry W Chase; Mary L Phillips; Carlos R Zevallos; Chaohui Guo; Alison E Hipwell
Journal:  Psychoneuroendocrinology       Date:  2016-01-12       Impact factor: 4.905

Review 7.  N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence.

Authors:  Beth Levant
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-06       Impact factor: 4.388

8.  Relationship of monoamine oxidase-A distribution volume to postpartum depression and postpartum crying.

Authors:  Julia Sacher; P Vivien Rekkas; Alan A Wilson; Sylvain Houle; Leslie Romano; Jinous Hamidi; Pablo Rusjan; Ian Fan; Donna E Stewart; Jeffrey H Meyer
Journal:  Neuropsychopharmacology       Date:  2014-07-30       Impact factor: 7.853

9.  Postpartum changes in affect-related behavior and VTA dopamine neuron activity in rats.

Authors:  Millie Rincón-Cortés; Anthony A Grace
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-10-23       Impact factor: 5.067

Review 10.  Sex differences and the neurobiology of affective disorders.

Authors:  David R Rubinow; Peter J Schmidt
Journal:  Neuropsychopharmacology       Date:  2018-07-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.